Tetsuo Kiso

888 total citations
34 papers, 748 citations indexed

About

Tetsuo Kiso is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Tetsuo Kiso has authored 34 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Physiology, 12 papers in Molecular Biology and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in Tetsuo Kiso's work include Pain Mechanisms and Treatments (18 papers), Ion channel regulation and function (6 papers) and Neuropeptides and Animal Physiology (6 papers). Tetsuo Kiso is often cited by papers focused on Pain Mechanisms and Treatments (18 papers), Ion channel regulation and function (6 papers) and Neuropeptides and Animal Physiology (6 papers). Tetsuo Kiso collaborates with scholars based in Japan, United States and United Kingdom. Tetsuo Kiso's co-authors include Yukinori Nagakura, Tomonari Watabiki, Tokio Yamaguchi, Atsuyuki Kohara, Takashi Toya, Masamichí Okada, Akihiko Iwai, Fumikazu Wanibuchi, Toshiaki Aoki and Nobuya Matsuoka and has published in prestigious journals such as Neuroscience, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

Tetsuo Kiso

34 papers receiving 724 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tetsuo Kiso Japan 16 402 213 203 137 127 34 748
Jonathan Bullman United Kingdom 14 267 0.7× 118 0.6× 118 0.6× 116 0.8× 155 1.2× 22 640
Stephen J. Medhurst United Kingdom 13 605 1.5× 253 1.2× 236 1.2× 208 1.5× 275 2.2× 13 1.0k
Chizuko Watanabe Japan 18 298 0.7× 256 1.2× 239 1.2× 105 0.8× 74 0.6× 65 878
Shailen K. Joshi United States 13 326 0.8× 138 0.6× 147 0.7× 87 0.6× 115 0.9× 15 531
Mario Barbieri Italy 17 272 0.7× 508 2.4× 579 2.9× 117 0.9× 293 2.3× 47 1.4k
Gricelda Hernandez United States 6 490 1.2× 237 1.1× 292 1.4× 82 0.6× 216 1.7× 8 896
Mark O. Urban United States 17 487 1.2× 396 1.9× 354 1.7× 155 1.1× 409 3.2× 27 1.2k
Kenneth Lamb United States 13 251 0.6× 158 0.7× 187 0.9× 33 0.2× 177 1.4× 15 832
Taeko Hata Japan 21 435 1.1× 333 1.6× 246 1.2× 83 0.6× 34 0.3× 94 1.1k
Chengshui Zhao United States 15 489 1.2× 384 1.8× 305 1.5× 87 0.6× 61 0.5× 18 875

Countries citing papers authored by Tetsuo Kiso

Since Specialization
Citations

This map shows the geographic impact of Tetsuo Kiso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuo Kiso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuo Kiso more than expected).

Fields of papers citing papers by Tetsuo Kiso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuo Kiso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuo Kiso. The network helps show where Tetsuo Kiso may publish in the future.

Co-authorship network of co-authors of Tetsuo Kiso

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuo Kiso. A scholar is included among the top collaborators of Tetsuo Kiso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuo Kiso. Tetsuo Kiso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kiso, Tetsuo, Tomonari Watabiki, & Toshihiro Sekizawa. (2020). ASP8477, a fatty acid amide hydrolase inhibitor, exerts analgesic effects in rat models of neuropathic and dysfunctional pain. European Journal of Pharmacology. 881. 173194–173194. 12 indexed citations
3.
Oka, Hiromasa, Kazuhiro Ikegai, Shohei Shirakami, et al.. (2018). Design, synthesis, and biological evaluation of novel biphenyl-4-carboxamide derivatives as orally available TRPV1 antagonists. Bioorganic & Medicinal Chemistry. 26(12). 3716–3726. 5 indexed citations
4.
Watabiki, Tomonari, et al.. (2017). In vitro and in vivo pharmacological characterization of ASP8477: A novel highly selective fatty acid amide hydrolase inhibitor. European Journal of Pharmacology. 815. 42–48. 17 indexed citations
5.
Inoue, Makoto, et al.. (2015). Discovery of a 1-isopropyltetrahydroisoquinoline derivative as an orally active N-type calcium channel blocker for neuropathic pain. Bioorganic & Medicinal Chemistry. 23(15). 4624–4637. 8 indexed citations
6.
7.
Sekiguchi, Mariko, Yoshihiro Kobashigawa, Motoji Kawasaki, et al.. (2011). An evaluation tool for FKBP12-dependent and -independent mTOR inhibitors using a combination of FKBP-mTOR fusion protein, DSC and NMR. Protein Engineering Design and Selection. 24(11). 811–817. 6 indexed citations
8.
Kiso, Tetsuo, et al.. (2010). Spinal mechanism of standard analgesics: Evaluation using mouse models of allodynia. European Journal of Pharmacology. 634(1-3). 40–45. 18 indexed citations
9.
Watabiki, Tomonari, Tetsuo Kiso, Noriko M. Tsuji, et al.. (2010). Amelioration of Neuropathic Pain by Novel Transient Receptor Potential Vanilloid 1 Antagonist AS1928370 in Rats without Hyperthermic Effect. Journal of Pharmacology and Experimental Therapeutics. 336(3). 743–750. 71 indexed citations
10.
11.
Kohara, Atsuyuki, Yukinori Nagakura, Tetsuo Kiso, et al.. (2007). Antinociceptive profile of a selective metabotropic glutamate receptor 1 antagonist YM-230888 in chronic pain rodent models. European Journal of Pharmacology. 571(1). 8–16. 20 indexed citations
12.
Nagakura, Yukinori, et al.. (2002). The effect of the selective 5-HT3 receptor agonist on ferret gut motility. Life Sciences. 71(11). 1313–1319. 14 indexed citations
13.
Kiso, Tetsuo, Yukinori Nagakura, Takashi Toya, et al.. (2001). Neurometer Measurement of Current Stimulus Threshold in Rats. Journal of Pharmacology and Experimental Therapeutics. 297(1). 352–356. 58 indexed citations
14.
Kiso, Tetsuo, et al.. (2001). Investigation of the effects of YM-31636, a novel 5-HT3 receptor agonist, on defecation in normal and constipated ferrets. European Journal of Pharmacology. 424(2). 151–157. 5 indexed citations
15.
Kiso, Tetsuo, et al.. (2001). A novel 5-HT3 receptor agonist, YM-31636, increases gastrointestinal motility without increasing abdominal pain. European Journal of Pharmacology. 431(1). 35–41. 14 indexed citations
16.
Ito, Hiroyuki, Tetsuo Kiso, Takeshi Kamato, et al.. (2000). Pharmacological profile of YM-31636, a novel 5-HT3 receptor agonist, in vitro. European Journal of Pharmacology. 409(2). 195–201. 17 indexed citations
17.
Nagakura, Yukinori, Tetsuo Kiso, Hiroyuki Ito, Keiji Miyata, & Tokio Yamaguchi. (2000). The role of 5-hydroxytryptamine3 and 5-hydroxytryptamine 4 receptors in the regulation of gut motility in the ferret. Life Sciences. 66(24). PL331–PL338. 5 indexed citations
18.
Nagakura, Yukinori, et al.. (1997). The Selective 5-Hydroxytryptamine (5-HT)4-Receptor Agonist RS67506 Enhances Lower Intestinal Propulsion in Mice.. The Japanese Journal of Pharmacology. 74(2). 209–212. 16 indexed citations
19.
Kataoka, Hiroaki, et al.. (1997). Pharmacological Profiles of a New Antiulcer Agent, SWR-215.. Biological and Pharmaceutical Bulletin. 20(1). 28–35. 1 indexed citations
20.
Ito, Hiroyuki, Shinobu Akuzawa, Rie Tsutsumi, et al.. (1995). Comparative study of the affinities of the 5-HT3 receptor antagonists, YM060, YM114 (KAE-393), granisetron and ondansetron in rat vagus nerve and cerebral cortex. Neuropharmacology. 34(6). 631–637. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonathan Bullman Breakdown of academic impact, for papers by Stephen J. Medhurst Breakdown of academic impact, for papers by Chizuko Watanabe Breakdown of academic impact, for papers by Shailen K. Joshi Breakdown of academic impact, for papers by Mario Barbieri Breakdown of academic impact, for papers by Gricelda Hernandez Breakdown of academic impact, for papers by Mark O. Urban Breakdown of academic impact, for papers by Kenneth Lamb Breakdown of academic impact, for papers by Taeko Hata Breakdown of academic impact, for papers by Chengshui Zhao
Rankless by CCL
2026